However, combination of these two drugs did not incite significant higher percentage of caspase 3/7 activity than treatment with single agent (Fig. 4d, p = 0.14) on PRL-3 low AML cells (patient no. 9). This evidence concerns the gene PTP4A3 and acute myeloid leukemia.